Concepts (100)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Acute-Phase Proteins | 1 | 2020 | 177 | 0.77 | Why? |
| Elasticity Imaging Techniques | 1 | 2020 | 194 | 0.71 | Why? |
| Leukocyte L1 Antigen Complex | 1 | 2020 | 238 | 0.71 | Why? |
| Liver Diseases | 3 | 2020 | 2698 | 0.61 | Why? |
| Aspartate Aminotransferases | 1 | 2020 | 1394 | 0.51 | Why? |
| Search Engine | 1 | 2020 | 628 | 0.48 | Why? |
| Liver | 1 | 2020 | 4007 | 0.30 | Why? |
| Inflammatory Bowel Diseases | 1 | 2020 | 3209 | 0.24 | Why? |
| Interleukin-6 | 1 | 2020 | 7522 | 0.23 | Why? |
| Internet | 1 | 2020 | 6204 | 0.23 | Why? |
| Cytokines | 2 | 2021 | 15010 | 0.22 | Why? |
| Neopterin | 1 | 2021 | 69 | 0.21 | Why? |
| Feces | 2 | 2021 | 4235 | 0.16 | Why? |
| Liver Function Tests | 1 | 2020 | 1325 | 0.13 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.12 | Why? |
| Biopsy | 1 | 2020 | 2811 | 0.11 | Why? |
| Coronavirus Infections | 6 | 2021 | 253789 | 0.10 | Why? |
| DNA, Viral | 1 | 2020 | 2521 | 0.10 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.10 | Why? |
| Hepatitis C, Chronic | 1 | 2018 | 973 | 0.09 | Why? |
| Biomarkers | 2 | 2020 | 23361 | 0.08 | Why? |
| Gastrointestinal Diseases | 1 | 2021 | 2580 | 0.07 | Why? |
| Gastrointestinal Microbiome | 1 | 2018 | 1961 | 0.07 | Why? |
| Austria | 2 | 2021 | 1259 | 0.07 | Why? |
| Severity of Illness Index | 3 | 2021 | 48226 | 0.07 | Why? |
| Reproducibility of Results | 1 | 2020 | 11304 | 0.06 | Why? |
| Immunosuppressive Agents | 1 | 2021 | 6331 | 0.06 | Why? |
| Anti-Inflammatory Agents | 1 | 2021 | 6153 | 0.06 | Why? |
| Inflammation | 2 | 2021 | 13255 | 0.05 | Why? |
| Sambucus | 1 | 2020 | 17 | 0.05 | Why? |
| STAT Transcription Factors | 1 | 2021 | 173 | 0.05 | Why? |
| Valine | 1 | 2021 | 359 | 0.05 | Why? |
| Humans | 13 | 2021 | 930598 | 0.04 | Why? |
| Nasal Sprays | 1 | 2020 | 234 | 0.04 | Why? |
| Male | 5 | 2021 | 367725 | 0.04 | Why? |
| Janus Kinases | 1 | 2021 | 414 | 0.04 | Why? |
| Carbamates | 1 | 2021 | 485 | 0.04 | Why? |
| Female | 5 | 2021 | 380317 | 0.04 | Why? |
| Pandemics | 7 | 2020 | 389249 | 0.04 | Why? |
| Povidone-Iodine | 1 | 2020 | 213 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2021 | 12361 | 0.04 | Why? |
| Epidemiologic Methods | 1 | 2020 | 392 | 0.04 | Why? |
| Pyrrolidines | 1 | 2021 | 558 | 0.04 | Why? |
| Aged | 4 | 2021 | 215776 | 0.04 | Why? |
| Plant Preparations | 1 | 2020 | 276 | 0.04 | Why? |
| Sofosbuvir | 1 | 2021 | 518 | 0.04 | Why? |
| Cross-Sectional Studies | 2 | 2020 | 53120 | 0.04 | Why? |
| Mouthwashes | 1 | 2020 | 432 | 0.04 | Why? |
| Imidazoles | 1 | 2021 | 631 | 0.04 | Why? |
| Prospective Studies | 1 | 2020 | 43301 | 0.04 | Why? |
| Purines | 1 | 2021 | 816 | 0.04 | Why? |
| Middle Aged | 4 | 2021 | 270681 | 0.04 | Why? |
| Azetidines | 1 | 2021 | 722 | 0.03 | Why? |
| Steroids | 1 | 2020 | 904 | 0.03 | Why? |
| Morbidity | 1 | 2020 | 1426 | 0.03 | Why? |
| Gastrointestinal Tract | 1 | 2021 | 1113 | 0.03 | Why? |
| Aged, 80 and over | 2 | 2020 | 88759 | 0.03 | Why? |
| Interleukin 1 Receptor Antagonist Protein | 1 | 2021 | 1165 | 0.03 | Why? |
| Sulfonamides | 1 | 2021 | 1294 | 0.03 | Why? |
| Smoking Cessation | 1 | 2020 | 826 | 0.03 | Why? |
| Viremia | 1 | 2018 | 1020 | 0.03 | Why? |
| Drug Combinations | 1 | 2021 | 3852 | 0.03 | Why? |
| Interferon-gamma | 1 | 2021 | 2711 | 0.03 | Why? |
| Pyrazoles | 1 | 2021 | 1791 | 0.03 | Why? |
| Drug Evaluation, Preclinical | 1 | 2021 | 3347 | 0.02 | Why? |
| Macrophages | 1 | 2021 | 2784 | 0.02 | Why? |
| Hepacivirus | 1 | 2018 | 1509 | 0.02 | Why? |
| Carcinoma, Hepatocellular | 1 | 2018 | 1222 | 0.02 | Why? |
| Republic of Korea | 1 | 2020 | 5858 | 0.02 | Why? |
| Adult | 3 | 2021 | 244371 | 0.02 | Why? |
| Antiviral Agents | 1 | 2021 | 41703 | 0.02 | Why? |
| Cost of Illness | 1 | 2018 | 1903 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2021 | 7268 | 0.02 | Why? |
| Liver Cirrhosis | 1 | 2018 | 1810 | 0.02 | Why? |
| Liver Neoplasms | 1 | 2018 | 1666 | 0.02 | Why? |
| Genotype | 1 | 2018 | 4697 | 0.02 | Why? |
| World Health Organization | 1 | 2018 | 4213 | 0.02 | Why? |
| Inpatients | 1 | 2021 | 5161 | 0.02 | Why? |
| Immunization, Passive | 1 | 2021 | 10067 | 0.02 | Why? |
| Treatment Outcome | 2 | 2021 | 51732 | 0.02 | Why? |
| Signal Transduction | 1 | 2021 | 7207 | 0.02 | Why? |
| Adenosine Monophosphate | 1 | 2021 | 5652 | 0.02 | Why? |
| Alanine | 1 | 2021 | 5687 | 0.02 | Why? |
| Disease Models, Animal | 1 | 2021 | 10998 | 0.02 | Why? |
| Case-Control Studies | 1 | 2021 | 17671 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2021 | 10649 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2021 | 7330 | 0.01 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.01 | Why? |
| Animals | 2 | 2021 | 78931 | 0.01 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 9335 | 0.01 | Why? |
| Anti-Bacterial Agents | 1 | 2020 | 10083 | 0.01 | Why? |
| Age Factors | 1 | 2018 | 21039 | 0.01 | Why? |
| Global Health | 1 | 2020 | 13911 | 0.01 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.01 | Why? |
| Prevalence | 1 | 2018 | 25773 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.01 | Why? |
| Lung | 1 | 2020 | 31049 | 0.01 | Why? |
| Adolescent | 1 | 2018 | 86841 | 0.01 | Why? |
| Young Adult | 1 | 2018 | 93724 | 0.01 | Why? |